Gene · 8081
Papers1,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of anxiety and depression on self-reported adverse reactions to COVID-19 vaccine: a cross-sectional study in Shanghai, China. | BMC Public Health | 2023 | 36869301 | PubTator, text mining | PubMed |
| The Coming of Age of Nucleic Acid Vaccines during COVID-19. | mSystems | 2023 | 36861992 | PubTator, text mining | PubMed |
| Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status. | Vaccines (Basel) | 2023 | 36851309 | PubTator, text mining | PubMed |
| COVID-19 Vaccination and Alcohol Consumption: Justification of Risks. | Pathogens | 2023 | 36839435 | PubTator, text mining | PubMed |
| Physiological reprogramming in vivo mediated by Sox4 pioneer factor activity. | bioRxiv | 2023 | 36824858 | PubTator, text mining | PubMed |
| The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread. | Nat Commun | 2023 | 36823200 | PubTator, text mining | PubMed |
| Genome-Scale CRISPR Screening Reveals Host Factors Required for Ribosome Formation and Viral Replication. | mBio | 2023 | 36809113 | PubTator, text mining | PubMed |
| Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies. | Eur J Hum Genet | 2023 | 36781956 | PubTator, text mining | PubMed |
| The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia. | Pharmacoeconomics | 2023 | 36720793 | PubTator, text mining | PubMed |
| The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. | bioRxiv | 2023 | 36711835 | PubTator, text mining | PubMed |
| COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells. | World J Gastroenterol | 2023 | 36688024 | PubTator, text mining | PubMed |
| The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine. | Viruses | 2023 | 36680244 | PubTator, text mining | PubMed |
| Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment. | Viruses | 2023 | 36680222 | PubTator, text mining | PubMed |
| C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo. | Biomedicines | 2023 | 36672645 | PubTator, text mining | PubMed |
| The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer. | Biomolecules | 2023 | 36671544 | PubTator, text mining | PubMed |
| Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma. | Biomed Pharmacother | 2023 | 36434955 | PubTator, text mining | PubMed |
| Sputnik V vaccine-related complications and its impression on inflammatory biomarkers in healthcare providers. | Indian J Med Microbiol | 2023 | 36357266 | PubTator, text mining | PubMed |
| Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques. | Emerg Microbes Infect | 2023 | 36239345 | PubTator, text mining | PubMed |
| Semiparametric additive time-varying coefficients model for longitudinal data with censored time origin. | Biometrics | 2023 | 34877661 | PubTator, text mining | PubMed |
| Recent and advanced nano-technological strategies for COVID-19 vaccine development. | Methods Microbiol | 2022 | 38620863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8081/papers?page=6